MedTrace Logo

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

NCT01015703 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-09-15

Study results available
· View outcomes & findings →

Summary

The study is being conducted to explore the safety and tolerability of CoVaccine HT in healthy male and female volunteers. In this study volunteers will receive intramuscular injections of CoVaccine HT.

Conditions

  • Vaccine

Interventions

BIOLOGICAL

CoVaccine HT

intramuscular injection, dose escalation

Sponsors & Collaborators

  • BTG International Inc.

    lead OTHER

Principal Investigators

  • Darren Wilbraham, MB., BS · Quintiles, Inc.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01015703 on ClinicalTrials.gov